Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19
Clinical trial NCT04479358 · TERMINATED
Trial details
- NCT number
- NCT04479358
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2024-03-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.